Funding for TB Test???
As per today's wonderful update,
Funding for TB Test???
As per today's wonderful update, the TB Project agencies (Gates Foundation and several Federal Institutes) appear to have significant interest in our tests and I'm sure they've been informed that the N-Assay will probably beat all other available TB tests.
Since raising $150,000 or so for the test's development might be a problem for NNLX, would it not be possible for any of those agencies to assist NNLX with the costs for developing the N-Assay TB test? This would be a very minor amount for a giant entity like The Gates Foundation,
One further point that I'm confused about. The TB project is using our BNP test based on a published journal article and they haven't demanded any further testing before using it.
Why does the N-Assay GBS test require further independent testing before it can be used since it's also based on a published journal article?
Comments welcome.
1
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Culmination of Brady Property Acquisition Rocky Shore Gold Ltd. (CSE: RSG) proudly announces the successful completion of the acquisition of the Brady Property through its wholly-owned subsidiary. This milestone complements the strategic vision of Rocky Shore to expand its portfolio and explore new opportunities. The Company commenced this journey with a cash payment of...
Continue Reading
IMCC and Maridive Join Forces for Offshore Excellence International Marine Construction Company (IMCC) and Maridive Offshore Projects have come together to establish a joint venture named 'One Marine'. This partnership aims to revolutionize offshore support vessel operations and other integrated marine services across various regions, including the Gulf Cooperation...
Continue Reading
Outlook for Growth in the CT Scanners Market The global market for CT scanners is on track for impressive growth, with forecasts suggesting it could hit USD 11.5 billion by 2034, a significant increase from an estimated USD 6.6 billion in 2023. This growth indicates a compound annual growth rate (CAGR) of about 5.0% over the next ten years. Innovations in technology,...
Continue Reading
Important Announcement for Shareholders of Sana Biotechnology The Gross Law Firm has important updates regarding the case involving Sana Biotechnology, Inc. (NASDAQ: SANA). Shareholders who purchased shares of SANA within the specified class period are encouraged to contact the firm regarding potential lead plaintiff appointments. It’s essential to note that being...
Continue Reading
Global Net Lease, Inc. Announces Dividend for Common Stock NEW YORK, Oct. 1, 2025 - Global Net Lease, Inc. (NYSE: GNL) recently declared a dividend of $0.190 per share of common stock. This payment, set for October 16, is to be allocated to all common stockholders who are on record as of the close of business on October 13. Understanding the Dividend Process The dividend...
Continue Reading